Inactive Instrument
LYSOGENE Share Price
Stocks
LYS
FR0013233475
Biotechnology & Medical Research
OTC Markets Traded
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 09/05/2014 | |
| Director of Finance/CFO | - | 01/11/2022 | |
Marie Trad
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 54 | 22/05/2019 | |
Peter Lichtlen
BRD | Director/Board Member | 58 | 01/04/2018 |
Carole Deffez
BRD | Director/Board Member | - | 26/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 55.26L | |
| -0.19% | -5.23% | +69.46% | +83.17% | 378.38Cr | |
| -6.03% | -2.65% | +65.57% | +140.77% | 299.76Cr | |
| +4.05% | -1.16% | -34.44% | -38.77% | 186.27Cr | |
| +3.03% | -6.85% | +82.14% | -48.29% | 176.81Cr | |
| -2.92% | -0.65% | +14.39% | +194.87% | 122.23Cr | |
| -0.36% | -9.66% | -16.52% | +15.91% | 85Cr | |
| -0.72% | -29.91% | +107.22% | - | 78Cr | |
| -4.41% | -0.20% | +118.42% | -61.78% | 77Cr | |
| +0.66% | -3.26% | -28.98% | -20.41% | 54Cr | |
| Average | -0.70% | -1.64% | +41.92% | +33.18% | 161.85Cr | |
| Weighted average by Cap. | -0.92% | -1.69% | +48.27% | +56.02% |
Employees
22
